デフォルト表紙
市場調査レポート
商品コード
1405875

敗血症診断薬の市場規模、シェア、動向分析レポート:製品別、技術別、病原体別、検査タイプ別、方法別、最終用途別、地域別、セグメント別予測、2024年~2030年

Sepsis Diagnostics Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Blood Culture Media), By Technology, By Pathogen, By Testing Type, By Method, By End-user, By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 120 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
敗血症診断薬の市場規模、シェア、動向分析レポート:製品別、技術別、病原体別、検査タイプ別、方法別、最終用途別、地域別、セグメント別予測、2024年~2030年
出版日: 2023年12月19日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

敗血症診断薬市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の敗血症診断薬市場規模は2030年までに18億2,000万米ドルに達する見込みです。

2024年から2030年までのCAGRは8.0%で拡大する見込みです。敗血症の高い有病率、技術的に高度な診断システムのイントロダクション、政府のイニシアチブの増加が、予測期間中の市場成長を促進すると予測されています。敗血症は、血液中に存在する病原性微生物に対する反応の結果として起こる血流疾患です。この疾患を患う患者は重度の炎症を起こし、入院が長期化します。

WHOによると、毎年約3,000万人がこの病気に罹患していると推定されています。NCBIによると、この疾患の患者数は若年層と高齢層で最も多いです。したがって、この疾患の早期診断の必要性が高まっています。WHOの報告によると、毎年世界中で120万人の子供と300万人の新生児がこの病気に罹患しています。このため、迅速な結果と患者の転帰の改善を目的とした診断ツールの需要がさらに高まっています。敗血症に対する規制承認の増加と技術的に高度な診断ソリューションの導入は、予測期間中の市場成長を促進すると予想されます。

2018年5月、米国を拠点とする新興診断ソリューション企業であるT2 Biosystems, Inc.は、ヒト全血検体中の特定の敗血症原因細菌病原体の検出を目的としたT2Bacteria Panelの米国FDA承認を取得しました。COVID-19のパンデミックは、敗血症用診断薬の成長に中程度の好影響を与えました。コロナウイルスの世界の広がりとCOVID-19患者における敗血症の発生は、おそらく迅速な検出への関心を拡大し、敗血症を認識するための機器、試薬、アッセイキットの使用を加速させるであろう。パンデミックによる封鎖やその他の制限により、人々は健康診断を受けるのが遅れ、検査の実施数や試薬の取引に影響を与えました。

パンデミックは、合併症に対してより無防備な高齢者を危険にさらし、肺炎に代表される激しい呼吸困難状態を含む、敗血症を引き起こす危険性を高めています。このため、COVID-19患者の敗血症の早期発見の必要性が生じています。世界敗血症連合(Global Sepsis Alliance)の推定によると、多臓器障害などの敗血症の症状は、入院後8~10日目にCOVID-19患者の約2.0~5.0%で発症します。この状況を管理するため、Biomedical Advanced Research and Development Authorityは2020年5月、COVID-19患者の敗血症を検出するデジタルアルゴリズムの開発に関するBeckman Coulterとの提携を延長しました。

敗血症診断薬市場レポートハイライト

  • 製品タイプ別では、血液培養培地が2023年に38.9%以上の売上シェアで市場を独占しました。
  • 微生物学技術セグメントが2023年の市場を独占し、全体の収益の48.9%以上の最大シェアを占めました。微生物培養は、実験室環境において感染性疾患の原因菌を検出するための主要かつゴールドスタンダードの方法です。
  • 細菌セグメントは、2023年に市場の86.0%の最大収益シェアを占めました。細菌性敗血症の症例の増加、院内感染発生の増加、実施される外科手術数の増加により、予測期間中、この分野がリードすると予測されています。
  • 従来型診断セグメントは、2023年に市場の57.6%の最大収益シェアを占めました。
  • 2023年の市場では、ラボ検査タイプが82.6%のシェアを占めました。検査室検査の進歩により、敗血症の検出が容易かつ迅速になり、患者の転帰改善につながった。
  • 北米が2023年の市場を独占し、44.1%以上の最大の収益シェアを占めました。敗血症や感染症の発生率の高さが、新しい診断ソリューションの需要を促進すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 敗血症診断薬市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の影響分析
    • 市場抑制要因分析
    • 業界の課題
  • 敗血症診断薬:市場分析ツール
    • ポーターの分析
    • 敗血症診断薬-マクロ経済分析

第4章 敗血症診断薬市場:セグメント分析、製品別、2018年~2030年

  • 敗血症診断薬市場:製品変動分析
  • 製品別
    • 機器
    • 血液培養培地
    • アッセイキットと試薬
    • ソフトウェア

第5章 敗血症診断薬市場:技術別セグメント分析、2018年~2030年

  • 敗血症診断薬市場:技術変動分析
  • 技術別
    • 微生物学
    • 分子診断学
    • 免疫学的検査
    • フローサイトメトリー
    • その他

第6章 敗血症診断薬市場:病原体別セグメント分析、2018年~2030年

  • 敗血症診断薬市場:病原変動分析
  • 病原体別
    • 細菌性敗血症
    • 真菌性敗血症
    • ウイルス性敗血症およびその他

第7章 敗血症診断薬市場:検査タイプ別セグメント分析、2018年~2030年

  • 敗血症診断薬市場:検査タイプの変動分析
  • 検査タイプ別
    • 臨床検査
    • ポイントオブケア検査

第8章 敗血症診断薬市場:セグメント分析、方法別、2018年~2030年

  • 敗血症診断薬市場:メソッドの変動分析
  • 方法別
    • 自動診断
    • 従来診断

第9章 敗血症診断薬市場:セグメント分析、最終用途別、2018年~2030年

  • 敗血症診断薬市場:エンドユーザーの変動分析
  • 最終用途別
    • 病院・クリニック
    • 病理学および基準研究所
    • 研究機関等

第10章 敗血症診断薬市場:地域別の推定・動向分析、製品別、技術別、病原体別、検査タイプ別、方法別、および最終用途別

  • 敗血症診断薬市場:地域別の見通し
  • 北米
    • 北米の敗血症診断薬市場推計・予測、2018年~2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州の敗血症診断薬市場推計・予測、2018年~2030年
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • デンマーク
    • スウェーデン
    • ノルウェー
    • ロシア
  • アジア太平洋
    • アジア太平洋の敗血症診断薬市場推計・予測、2018年~2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
    • シンガポール
  • ラテンアメリカ
    • ラテンアメリカの敗血症診断薬市場推計・予測、2018年~2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカの敗血症診断薬市場推計・予測、2018年~2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第11章 競合情勢

  • 企業の分類
  • 企業の市場での位置付け
    • マーケットリーダー
  • 企業プロファイル
  • 企業プロファイル
    • Biomerieux Sa
    • Becton, Dickinson And Company(Bd)
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-la Roche
    • Luminex Corporation
    • Danaher(Beckman Coulter, Inc.)
    • Bruker Corporation
    • Cepheid
    • Koninklijke Philips Nv
    • Immunexpress, Inc.
図表

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies'/technology disruptors/innovators
  • Table 3 North America sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 4 North America sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 5 North America sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 6 North America sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 7 North America sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 8 North America sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 9 North America sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 10 North America sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 11 U.S. sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 12 U.S. sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 13 U.S. sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 14 U.S. sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 15 U.S. sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 16 U.S. sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 17 U.S. sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 18 Canada sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 19 Canada sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 20 Canada sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 21 Canada sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 22 Canada sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 23 Canada sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 24 Canada sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 25 Europe sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 26 Europe sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 27 Europe sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 28 Europe sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 29 Europe sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 30 Europe sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 31 Europe sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 32 Europe sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 33 Germany sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 34 Germany sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 35 Germany sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 36 Germany sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 37 Germany sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 38 Germany sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 39 Germany sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 40 UK sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 41 UK sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 42 UK sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 43 UK sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 44 UK sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 45 UK sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 46 UK sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 47 France sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 48 France sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 49 France sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 50 France sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 51 France sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 52 France sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 53 France sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 54 Italy sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 55 Italy sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 56 Italy sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 57 Italy sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 58 Italy sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 59 Italy sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 60 Italy sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 61 Spain sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 62 Spain sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 63 Spain sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 64 Spain sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 65 Spain sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 66 Spain sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 67 Spain sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 68 Russia sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 69 Russia sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 70 Russia sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 71 Russia sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 72 Russia sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 73 Russia sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 74 Russia sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 75 Denmark sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 76 Denmark sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 77 Denmark sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 78 Denmark sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 79 Denmark sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 80 Denmark sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 81 Denmark sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 82 Sweden sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 83 Sweden sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 84 Sweden sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 85 Sweden sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 86 Sweden sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 87 Sweden sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 88 Sweden sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 89 Norway sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 90 Norway sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 91 Norway sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 92 Norway sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 93 Norway sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 94 Norway sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 95 Norway sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 96 Asia Pacific sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 97 Asia Pacific sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 98 Asia Pacific sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 99 Asia Pacific sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 100 Asia Pacific sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 101 Asia Pacific sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 102 Asia Pacific sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 103 Asia Pacific sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 104 China sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 105 China sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 106 China sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 107 China sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 108 China sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 109 China sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 110 China sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 111 India sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 112 India sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 113 India sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 114 India sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 115 India sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 116 India sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 117 India sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 118 Australia sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 119 Australia sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 120 Australia sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 121 Australia sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 122 Australia sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 123 Australia sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 124 Australia sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 125 Japan sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 126 Japan sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 127 Japan sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 128 Japan sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 129 Japan sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 130 Japan sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 131 Japan sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 132 South Korea sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 133 South Korea sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 134 South Korea sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 135 South Korea sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 136 South Korea sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 137 South Korea sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 138 South Korea sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 139 Singapore sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 140 Singapore sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 141 Singapore sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 142 Singapore sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 143 Singapore sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 144 Singapore sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 145 Singapore sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 146 Thailand sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 147 Thailand sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 148 Thailand sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 149 Thailand sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 150 Thailand sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 151 Thailand sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 152 Thailand sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 153 Latin America sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 154 Latin America sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 155 Latin America sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 156 Latin America sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 157 Latin America sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 158 Latin America sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 159 Latin America sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 160 Latin America sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 161 Brazil sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 162 Brazil sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 163 Brazil sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 164 Brazil sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 165 Brazil sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 166 Brazil sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 167 Brazil sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 168 Mexico sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 169 Mexico sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 170 Mexico sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 171 Mexico sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 172 Mexico sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 173 Mexico sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 174 Mexico sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 175 Argentina sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 176 Argentina sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 177 Argentina sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 178 Argentina sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 179 Argentina sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 180 Argentina sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 181 Argentina sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 182 MEA sepsis diagnostics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 183 MEA sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 184 MEA sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 185 MEA sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 186 MEA sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 187 MEA sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 188 MEA sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 189 MEA sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 190 South Africa sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 191 South Africa sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 192 South Africa sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 193 South Africa sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 194 South Africa sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 195 South Africa sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 196 South Africa sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 197 Saudi Arabia sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 198 Saudi Arabia sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 199 Saudi Arabia sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 200 Saudi Arabia sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 201 Saudi Arabia sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 202 Saudi Arabia sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 203 Saudi Arabia sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 204 UAE sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 205 UAE sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 206 UAE sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 207 UAE sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 208 UAE sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 209 UAE sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 210 UAE sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)
  • Table 211 Kuwait sepsis diagnostics market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 212 Kuwait sepsis diagnostics market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 213 Kuwait sepsis diagnostics market estimates and forecasts, by pathogen, 2018 - 2030 (USD Million)
  • Table 214 Kuwait sepsis diagnostics market estimates and forecasts, by bacterial sepsis, 2018 - 2030 (USD Million)
  • Table 215 Kuwait sepsis diagnostics market estimates and forecasts, by testing type, 2018 - 2030 (USD Million)
  • Table 216 Kuwait sepsis diagnostics market estimates and forecasts, by method, 2018 - 2030 (USD Million)
  • Table 217 Kuwait sepsis diagnostics market estimates and forecasts, by end-user, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Sepsis diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Segment snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Sepsis diagnostics market dynamics
  • Fig. 15 Porter's Five Force Analysis
  • Fig. 16 Sepsis diagnostics market: PESTEL analysis
  • Fig. 17 Sepsis diagnostics market: Product outlook and key takeaways
  • Fig. 18 Sepsis diagnostics market: Product movement analysis
  • Fig. 19 Instrument sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Blood culture media sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Assay kits and reagents sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Software market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Sepsis diagnostics market: Technology outlook and key takeaways
  • Fig. 24 Sepsis diagnostics market: Technology movement analysis
  • Fig. 25 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Polymerase chain reaction market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 DNA microarrays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Syndromic panel testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Immunoassays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Sepsis diagnostics market: Pathogen outlook and key takeaways
  • Fig. 35 Sepsis diagnostics market: Pathogen movement analysis
  • Fig. 36 Bacterial sepsis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Gram-positive bacteria market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Gram-negative bacteria market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Fungal sepsis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Viral sepsis and others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Sepsis diagnostics market: Testing type outlook and key takeaways
  • Fig. 42 Sepsis diagnostics market: Testing type movement analysis
  • Fig. 43 Laboratory testing market estimates and forecast, 2018 - 2030, USD Million
  • Fig. 44 Point-of-care testing market estimates and forecast, 2018 - 2030, USD Million
  • Fig. 45 Sepsis diagnostics market: Method outlook and key takeaways
  • Fig. 46 Sepsis diagnostics market: Method movement analysis
  • Fig. 47 Automated diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Conventional diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Sepsis diagnostics market: End user outlook and key takeaways
  • Fig. 50 Sepsis diagnostics market: End-user movement analysis
  • Fig. 51 Hospitals & clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Pathology & reference laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Research institutes and others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Sepsis diagnostic market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 55 Regional marketplace: Key takeaways
  • Fig. 56 North America sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 U.S. sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Canada sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Europe sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 UK sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Germany sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 France sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Spain sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Italy sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Denmark sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Sweden sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Norway sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Russia sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Rest of Europe sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Asia Pacific sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Japan sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 China sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 India sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Australia sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Thailand sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 South Korea sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Singapore sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 96 Rest of Asia Pacific sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Latin America sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Brazil sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Mexico sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Argentina sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 104 Rest of LATAM sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 105 MEA sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 106 Key country dynamics
  • Fig. 107 South Africa sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 108 Key country dynamics
  • Fig. 109 Saudi Arabia sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 110 Key country dynamics
  • Fig. 111 UAE sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 112 Key country dynamics
  • Fig. 113 Kuwait sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 114 Rest of MEA sepsis diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 115 Market participant categorization
  • Fig. 116 Company market positioning
  • Fig. 117 Sepsis diagnostics market share analysis, 2023
  • Fig. 118 Company heat map analysis
  • Fig. 119 Strategic framework
目次
Product Code: GVR-1-68038-352-2

Sepsis Diagnostics Market Growth & Trends:

The global sepsis diagnostics market size is expected to reach USD 1.82 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.0% from 2024 to 2030. The high prevalence of sepsis, the introduction of technologically advanced diagnostic systems, and increasing government initiatives are expected to propel market growth over the forecast period. Sepsis is a bloodstream disease that occurs as a result of a response to pathogenic microorganisms present in the blood. Patients suffering from this disease experience severe inflammation, which leads to prolonged hospitalization.

According to the WHO, around 30 million people are estimated to be affected by this disease every year. The NCBI stated that the largest number of this condition have been observed in the youngest and oldest age groups. Thus, there is a rising need for the early diagnosis of this disease. The WHO reported that every year, 1.2 million children and 3 million newborns are affected by this disease across the world. This has further boosted the demand for its diagnostic tools for quick results and improved patient outcomes. Increasing regulatory approval and the introduction of technologically advanced diagnostic solutions for sepsis are expected to facilitate market growth over the forecast period.

In May 2018, T2 Biosystems, Inc., a U.S.-based emerging diagnostic solutions company, received the U.S. FDA approval for its T2Bacteria Panel, intended for the detection of specific sepsis-causing bacterial pathogens in human whole blood specimens. The COVID-19 pandemic affected the growth of diagnostics products for sepsis in a moderately positive way. The worldwide spread of Coronavirus and the arising instances of sepsis among COVID-19 patients are probably going to expand the interest for fast detection, speeding up the use of instruments, reagents, and assay kits for recognition of sepsis. Pandemic-induced lockdown and other restrictions made individuals delay going through wellbeing checkups, influencing the number of tests performed and reagent deals.

The pandemic has featured the risk upon elders, who are more defenseless to complications, including intense respiratory distress condition, typically because of pneumonia, which builds the risk of creating sepsis. This has created a need for the early detection of sepsis among patients with COVID-19. Symptoms of sepsis, such as multiorgan injuries, develop in around 2.0 to 5.0% of COVID-19 cases 8 to 10 days post-hospitalization, based on the estimates of the Global Sepsis Alliance. To manage this situation, the Biomedical Advanced Research and Development Authority, in May 2020, extended its partnership with Beckman Coulter for the development of a digital algorithm to detect sepsis in patients with COVID-19.

Sepsis Diagnostics Market Report Highlights:

  • Based on product type, blood culture media dominated the market in 2023 with a revenue share of more than 38.9%, as blood culture is considered the most cost-effective and convenient testing mode.
  • The microbiology technology segment dominated the market in 2023 and held the largest share of more than 48.9% of the overall revenue. Microbial culture is the primary and gold standard method for detecting infectious disease-causing organisms in laboratory settings.
  • Bacterial segment held the largest revenue share of 86.0% of the market in 2023. It is anticipated to lead over the forecast period due to the rise in cases of bacterial sepsis, higher occurrence of hospital-transmitted infections, and rising number of surgical procedures conducted.
  • The conventional diagnostics segment held the largest revenue share of 57.6% of the market in 2023.
  • The laboratory testing type segment dominated the market in 2023 with a share of 82.6%. Advancements in laboratory testing have made it easier and faster to detect sepsis, leading to better outcomes for patients.
  • North America dominated the market in 2023 and held the largest revenue share of more than 44.1%. High incidence of sepsis and infectious diseases is expected to fuel demand for novel diagnostic solutions.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation And Scope
  • 1.1 Market Definitions
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List Of Secondary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Product And Technology Snapshot
  • 2.3 Pathogen And Testing Type Snapshot
  • 2.4 Method And End-user Snapshot
  • 2.5 Competitive Landscape Snapshot

Chapter 3 Sepsis Diagnostics Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Related/ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Impact Analysis
      • 3.2.1.1 Increase In Prevalence Of Sepsis
      • 3.2.1.2 Rise In Incidence Of Hospital-acquired Infections
      • 3.2.1.3 Increase In The Number Of Pneumonia Cases
      • 3.2.1.4 Approval And Launch Of Advanced Sepsis Diagnostic System
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 High Cost Of Automated Diagnostic Instruments
      • 3.2.2.2 Lack Of Awareness About Sepsis
    • 3.2.3 Industry Challenges
      • 3.2.3.1 Scientific And Clinical Challenges Associated With Sepsis
  • 3.3 Sepsis Diagnostics: Market Analysis Tools
    • 3.3.1 Porter's Analysis
    • 3.3.2 Sepsis Diagnostics - Macroeconomic Analysis

Chapter 4 Sepsis Diagnostics Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 4.1 Sepsis Diagnostics Market: Product Movement Analysis
  • 4.2 Sepsis Diagnostics Market Estimates & Forecast, By Product (USD Million)
    • 4.2.1 Instrument
    • 4.2.2 Blood Culture Media
    • 4.2.3 Assay Kits And Reagents
    • 4.2.4 Software

Chapter 5 Sepsis Diagnostics Market: Segment Analysis, By Technology, 2018 - 2030 (USD Million)

  • 5.1 Sepsis Diagnostics Market: Technology Movement Analysis
  • 5.2 Sepsis Diagnostics Market Estimates & Forecast, By Technology (USD Million)
    • 5.2.1 Microbiology
    • 5.2.2 Molecular Diagnostics
      • 5.2.2.1 Polymerase Chain Reaction (Pcr)
      • 5.2.2.2 Dna Microarrays
      • 5.2.2.3 Syndromic Panel Testing
      • 5.2.2.4 Others
    • 5.2.3 Immunoassays
    • 5.2.4 Flow Cytometry
    • 5.2.5 Others

Chapter 6 Sepsis Diagnostics Market: Segment Analysis, By Pathogen, 2018 - 2030 (USD Million)

  • 6.1 Sepsis Diagnostics Market: Pathogen Movement Analysis
  • 6.2 Sepsis Diagnostics Market Estimates & Forecast, By Pathogen (USD Million)
    • 6.2.1 Bacterial Sepsis
      • 6.2.1.1 Gram-positive Bacteria
      • 6.2.1.2 Gram-negative Bacteria
    • 6.2.2 Fungal Sepsis
    • 6.2.3 Viral Sepsis And Others

Chapter 7 Sepsis Diagnostics Market: Segment Analysis, By Testing Type, 2018 - 2030 (USD Million)

  • 7.1 Sepsis Diagnostics Market: Testing Type Movement Analysis
  • 7.2 Sepsis Diagnostics Market Estimates & Forecast, By Testing Type (USD Million)
    • 7.2.1 Laboratory Testing
    • 7.2.2 Point-of-care Testing

Chapter 8 Sepsis Diagnostics Market: Segment Analysis, By Method, 2018 - 2030 (USD Million)

  • 8.1 Sepsis Diagnostics Market: Method Movement Analysis
  • 8.2 Sepsis Diagnostics Market Estimates & Forecast, By Method (USD Million)
    • 8.2.1 Automated Diagnostics
    • 8.2.2 Conventional Diagnostics

Chapter 9 Sepsis Diagnostics Market: Segment Analysis, By End-user, 2018 - 2030 (USD Million)

  • 9.1 Sepsis Diagnostics Market: End-user Movement Analysis
  • 9.2 Sepsis Diagnostics Market Estimates & Forecast, By End-user (USD Million)
    • 9.2.1 Hospitals & Clinics
    • 9.2.2 Pathology & Reference Laboratories
    • 9.2.3 Research Institutes And Others

Chapter 10 Sepsis Diagnostic Market: Regional Estimates And Trend Analysis, By Product, By Technology, By Pathogen, By Testing Type, By Method, & By End-user

  • 10.1 Sepsis Diagnostic Market: Regional Outlook
  • 10.2 North America
    • 10.2.1 North America Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.2.1.1 Regulatory Framework
      • 10.2.1.2 Reimbursement Scenario
    • 10.2.2 U.s.
      • 10.2.2.1 Key Country Dynamics
      • 10.2.2.2 U.s. Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.2.2.3 Market & Competitive Scenario
    • 10.2.3 Canada
      • 10.2.3.1 Key Country Dynamics
      • 10.2.3.2 Canada Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.2.3.3 Market And Competitive Scenario
  • 10.3 Europe
    • 10.3.1 Europe Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.1.1 Regulatory Framework
      • 10.3.1.2 Reimbursement Scenario
    • 10.3.2 Uk
      • 10.3.2.1 Key Country Dynamics
      • 10.3.2.2 Uk Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.2.3 Market & Competitive Scenario
    • 10.3.3 Germany
      • 10.3.3.1 Key Country Dynamics
      • 10.3.3.2 Germany Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.3.3 Market & Competitive Scenario
    • 10.3.4 France
      • 10.3.4.1 Key Country Dynamics
      • 10.3.4.2 France Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.4.3 Market & Competitive Scenario
    • 10.3.5 Spain
      • 10.3.5.1 Key Country Dynamics
      • 10.3.5.2 Spain Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.5.3 Market & Competitive Scenario
    • 10.3.6 Italy
      • 10.3.6.1 Key Country Dynamics
      • 10.3.6.2 Italy Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.6.3 Market & Competitive Scenario
    • 10.3.7 Denmark
      • 10.3.7.1 Key Country Dynamics
      • 10.3.7.2 Denmark Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.7.3 Market & Competitive Scenario
    • 10.3.8 Sweden
      • 10.3.8.1 Key Country Dynamics
      • 10.3.8.2 Sweden Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.8.3 Market & Competitive Scenario
    • 10.3.9 Norway
      • 10.3.9.1 Key Country Dynamics
      • 10.3.9.2 Norway Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.9.3 Market & Competitive Scenario
    • 10.3.10 Russia
      • 10.3.10.1 Key Country Dynamics
      • 10.3.10.2 Russia Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.3.10.3 Market & Competitive Scenario
      • 10.3.10.4 Rest Of Europe Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.4.1.1 Regulatory Framework
      • 10.4.1.2 Reimbursement Scenario
    • 10.4.2 Japan
      • 10.4.2.1 Key Country Dynamics
      • 10.4.2.2 Japan Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.4.2.3 Market And Competitive Scenario
    • 10.4.3 China
      • 10.4.3.1 Key Country Dynamics
      • 10.4.3.2 China Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.4.3.3 Market And Competitive Scenario
    • 10.4.4 India
      • 10.4.4.1 Key Country Dynamics
      • 10.4.4.2 India Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.4.4.3 Market And Competitive Scenario
    • 10.4.5 Australia
      • 10.4.5.1 Key Country Dynamics
      • 10.4.5.2 Australia Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.4.5.3 Market And Competitive Scenario
    • 10.4.6 Thailand
      • 10.4.6.1 Key Country Dynamics
      • 10.4.6.2 Thailand Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.4.6.3 Market And Competitive Scenario
    • 10.4.7 South Korea
      • 10.4.7.1 Key Country Dynamics
      • 10.4.7.2 South Korea Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.4.7.3 Market And Competitive Scenario
    • 10.4.8 Singapore
      • 10.4.8.1 Key Country Dynamics
      • 10.4.8.2 Singapore Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.4.8.3 Market And Competitive Scenario
      • 10.4.8.4 Rest Of Asia Pacific Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.5 Latin America
    • 10.5.1 Latin America Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.5.1.1 Regulatory Framework
      • 10.5.1.2 Reimbursement Scenario
    • 10.5.2 Brazil
      • 10.5.2.1 Key Country Dynamics
      • 10.5.2.2 Brazil Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.5.2.3 Market And Competitive Scenario
    • 10.5.3 Mexico
      • 10.5.3.1 Key Country Dynamics
      • 10.5.3.2 Mexico Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.5.3.3 Market And Competitive Scenario
    • 10.5.4 Argentina
      • 10.5.4.1 Key Country Dynamics
      • 10.5.4.2 Argentina Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.5.4.3 Market And Competitive Scenario
      • 10.5.4.4 Rest Of Latam Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.6 MEA
    • 10.6.1 MEA Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.6.1.1 Regulatory Framework
      • 10.6.1.2 Reimbursement Scenario
    • 10.6.2 South Africa
      • 10.6.2.1 Key Country Dynamics
      • 10.6.2.2 South Africa Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.6.2.3 Market And Competitive Scenario
    • 10.6.3 Saudi Arabia
      • 10.6.3.1 Key Country Dynamics
      • 10.6.3.2 Saudi Arabia Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.6.3.3 Market And Competitive Scenario
    • 10.6.4 UAE
      • 10.6.4.1 Key Country Dynamics
      • 10.6.4.2 UAE Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.6.4.3 Competitive Scenario
    • 10.6.5 Kuwait
      • 10.6.5.1 Key Country Dynamics
      • 10.6.5.2 Kuwait Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 10.6.5.3 Market And Competitive Scenario
      • 10.6.5.4 Rest Of MEA Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 11 Competitive Landscape

  • 11.1 Company Categorization
  • 11.2 Company Market Positioning
    • 11.2.1 Market Leaders
      • 11.2.1.1 Sepsis Diagnostics Market Share Analysis, 2023
  • 11.3 Company Profiles
  • 11.3 Company Profiles
    • 11.3.1 Biomerieux Sa
      • 11.3.1.1 Company Overview
      • 11.3.1.2 Financial Performance
      • 11.3.1.3 Product Benchmarking
      • 11.3.1.4 Strategic Initiatives
    • 11.3.2 Becton, Dickinson And Company (Bd)
      • 11.3.2.1 Company Overview
      • 11.3.2.2 Financial Performance
      • 11.3.2.3 Product Benchmarking
      • 11.3.2.4 Strategic Initiatives
    • 11.3.3 Thermo Fisher Scientific, Inc.
      • 11.3.3.1 Company Overview
      • 11.3.3.2 Financial Performance
      • 11.3.3.3 Product Benchmarking
      • 11.3.3.4 Strategic Initiatives
    • 11.3.4 F. Hoffmann-la Roche
      • 11.3.4.1 Company Overview
      • 11.3.4.2 Financial Performance
      • 11.3.4.3 Product Benchmarking
      • 11.3.4.4 Strategic Initiatives
    • 11.3.5 Luminex Corporation
      • 11.3.5.1 Company Overview
      • 11.3.5.2 Financial Performance
      • 11.3.5.3 Product Benchmarking
      • 11.3.5.4 Strategic Initiatives
    • 11.3.6 Danaher (Beckman Coulter, Inc.)
      • 11.3.6.1 Company Overview
      • 11.3.6.2 Financial Performance
      • 11.3.6.3 Product Benchmarking
      • 11.3.6.4 Strategic Initiatives
    • 11.3.7 Bruker Corporation
      • 11.3.7.1 Company Overview
      • 11.3.7.2 Financial Performance
      • 11.3.7.3 Product Benchmarking
      • 11.3.7.4 Strategic Initiatives
    • 11.3.8 Cepheid
      • 11.3.8.1 Company Overview
      • 11.3.8.2 Financial Performance
      • 11.3.8.3 Product Benchmarking
      • 11.3.8.4 Strategic Initiatives
    • 11.3.9 Koninklijke Philips N.v.
      • 11.3.9.1 Company Overview
      • 11.3.9.2 Financial Performance
      • 11.3.9.3 Product Benchmarking
      • 11.3.9.4 Strategic Initiatives
    • 11.3.10 Immunexpress, Inc.
      • 11.3.10.1 Company Overview
      • 11.3.10.2 Financial Performance
      • 11.3.10.3 Product Benchmarking
      • 11.3.10.4 Strategic Initiatives